Intrexon Corporation , a leader in synthetic biology, today announced that it has entered into a definitive agreement to acquire, for approximately $26 million, San Diego-based Medistem, Inc. a pioneer in the development of Endometrial Regenerative Cells , universal donor adult stem cells that stimulate new blood vessel formation and are capable of ... (more)
http://www.globenewswire.com/news-release/2013/12/20/598738/10062260/en/Intrexon-to-Acquire-Medistem-to-Generate-Multipotent-Cells.html
http://www.globenewswire.com/news-release/2013/12/20/598738/10062260/en/Intrexon-to-Acquire-Medistem-to-Generate-Multipotent-Cells.html
No comments:
Post a Comment